Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit (HYPIC)
Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit: Morbidity-mortality Impact
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Metz, France, 57085
- CHR Metz-Thionville
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Hospitalized patient in the Therapeutic Cardiac Failure Unit in the CHR Metz-Thionville
- Patient with congestive heart failure
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite of death and re-hospitalization
Time Frame: Month 3
|
The number of death for any reason and re-hospitalization for congestive heart failure
|
Month 3
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Death
Time Frame: Month 3
|
Percentage of death for any reason
|
Month 3
|
|
Re-hospitalization
Time Frame: Month 3
|
Percentage of re-hospitalization for congestive heart failure
|
Month 3
|
|
Length of stay
Time Frame: Month 3
|
Days spent at the hospital
|
Month 3
|
|
Incidence of hypokalemia
Time Frame: Month 3
|
Percentage of incidence during the stay of hypokalemia
|
Month 3
|
|
Prevalence of hypokalemia
Time Frame: Month 3
|
Percentage of initial prevalence during the stay of hypokalemia
|
Month 3
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2017-03Obs-CHRMT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.